The scientist’s investigation covers issues in Atrophy, Central nervous system disease, Pathology, Parkinsonism and Parkinson's disease. His Atrophy research includes elements of Predictive value of tests, Striatonigral Degeneration, Pure autonomic failure, Cerebellar ataxia and Neuroscience. His Striatonigral Degeneration study deals with Glial cytoplasmic inclusion intersecting with Multiple system atrophy.
The study incorporates disciplines such as Progressive supranuclear palsy and Corticobasal degeneration in addition to Central nervous system disease. His Parkinsonism research includes themes of Differential diagnosis, Pathological, Neuroimaging and Pediatrics. His research in Parkinson's disease intersects with topics in Anesthesia and Crossover study.
Gregor K. Wenning mainly focuses on Atrophy, Pathology, Parkinsonism, Internal medicine and Neuroscience. His studies deal with areas such as Neurology, Disease, Parkinson's disease, Striatonigral Degeneration and Cerebellar ataxia as well as Atrophy. His work deals with themes such as Basal ganglia, Striatum and Putamen, which intersect with Pathology.
His Parkinsonism study integrates concerns from other disciplines, such as Progressive supranuclear palsy, Central nervous system disease, Differential diagnosis, Pure autonomic failure and Pediatrics. His Internal medicine research incorporates elements of Gastroenterology, Endocrinology, Surgery and Cardiology. His Neuroscience study incorporates themes from Neuropathology and Neurodegeneration.
Gregor K. Wenning mainly investigates Atrophy, Internal medicine, Neurology, Disease and Parkinson's disease. The various areas that Gregor K. Wenning examines in his Atrophy study include Neurodegeneration, Neuroscience and Parkinsonism. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Oncology and Cardiology.
As part of one scientific family, Gregor K. Wenning deals mainly with the area of Neurology, narrowing it down to issues related to the Physical medicine and rehabilitation, and often Rating scale. He has researched Disease in several fields, including Physical therapy, Clinical trial and Quality of life. His Parkinson's disease study combines topics in areas such as Differential diagnosis and Middle cerebellar peduncle.
His primary areas of investigation include Atrophy, Disease, Progressive supranuclear palsy, Internal medicine and Neuroscience. His work carried out in the field of Atrophy brings together such families of science as Neurology, Neurodegeneration, Parkinson's disease and Parkinsonism. His research integrates issues of Gastroenterology, Differential diagnosis and Cohort in his study of Parkinsonism.
His studies in Disease integrate themes in fields like Genome-wide association study, Oncology, Bioinformatics, Research design and Biomarker. The study incorporates disciplines such as Gait, Physical medicine and rehabilitation, Fractional anisotropy and Clinical trial in addition to Progressive supranuclear palsy. His Pure autonomic failure research is multidisciplinary, incorporating perspectives in Ataxia, Physical therapy and Movement disorders.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman;G. K. Wenning;P. A. Low;D. J. Brooks.
Neurology (2008)
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
Christopher G. Goetz;Werner Poewe;Olivier Rascol;Cristina Sampaio.
Movement Disorders (2004)
Consensus statement on the diagnosis of multiple system atrophy
S Gilman;P.A Low;N Quinn;A Albanese.
Journal of the Neurological Sciences (1999)
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
Irene Litvan;Kailash P. Bhatia;David J. Burn;Christopher G. Goetz.
Movement Disorders (2003)
Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.
G. K. Wenning;Y. Ben Shlomo;M. Magalhães;S. E. Danie.
Brain (1994)
Multiple system atrophy: A review of 203 pathologically proven cases
G. K. Wenning;F. Tison;Y. ben Shlomo;S. E. Daniel.
Movement Disorders (1997)
The diagnosis of Parkinson's disease
Eduardo Tolosa;Gregor Wenning;Werner Poewe.
Lancet Neurology (2006)
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz.
Movement Disorders (2017)
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
Stefan Kiechl;Georg Schett;Gregor Wenning;Kurt Redlich.
Circulation (2004)
Multiple system atrophy
Gregor K Wenning;Carlo Colosimo;Felix Geser;Werner Poewe.
Lancet Neurology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Innsbruck Medical University
Innsbruck Medical University
University College London
Medical University of Vienna
University of California, San Diego
Innsbruck Medical University
University of Otago
University of Tübingen
Philipp University of Marburg
University of Padua
Autonomous University of Madrid
Bangor University
Nanjing Tech University
Imperial College London
Université Laval
University of Tokyo
Roche (Switzerland)
University of Bristol
Rice University
Cardiff University
National Aeronautics and Space Administration
University of Montreal
Michigan State University
Istituto Superiore di Sanità
University of Milano-Bicocca
University College London